分子诊断服务平台Mapmygenome通过战略性收购Microbiome Insights，巩固了其在全球基因组学领域的领导地位-动脉网

Mapmygenome cements global leadership in Genomics with strategic acquisition of Canada's Microbiome Insights

CISION 等信源发布 2025-05-29 22:30



可切换为仅中文







HYDERABAD, India

印度海得拉巴

and

和

VANCOUVER, BC

加拿大温哥华

，

May 29, 2025

2025年5月29日

/PRNewswire/ -- Mapmygenome, an AI-driven leader in genomics and personalized health, announced the strategic acquisition of Microbiome Insights, a global leader in microbial sequencing. The acquisition includes Microbiome Insights' CAP-accredited Canadian laboratory and rich intellectual property, boosting Mapmygenome's scientific prowess and enabling its global expansion..

/PRNewswire/ -- Mapmygenome，一家以人工智能驱动的基因组学和个性化健康领域的领导者，宣布战略性收购全球微生物测序领域的领导者Microbiome Insights。此次收购包括Microbiome Insights拥有CAP认证的加拿大实验室及其丰富的知识产权，增强了Mapmygenome的科学实力，并推动其全球扩展。

继续阅读

Mapmygenome Goes Global

Mapmygenome走向全球

Having supported over 600 global clients with 1,000+ cutting-edge microbiome studies, Microbiome Insights is a leading partner for academic, clinical, and industry researchers. Its founders, Dr.

凭借支持了600多家全球客户以及1000多项前沿微生物组研究，Microbiome Insights 成为了学术、临床和行业研究人员的领先合作伙伴。公司创始人，博士。

Brett Finlay

布雷特·芬利

, Dr.

，博士。

William Mohn

威廉·莫恩

, and

，以及

Malcolm Kendall

马尔科姆·肯德尔

, are recognized global experts.

，是公认的全球专家。

Microbiome Insights will maintain its role as a premier CRO, empowering global research. Simultaneously, Mapmygenome will introduce its integrated genomics and microbiome testing services to

微生物组洞察将继续其作为顶级合同研究组织的角色，推动全球研究。同时，Mapmygenome 将推出其整合的基因组学和微生物组测试服务。

North America

北美

, making holistic, data-driven health solutions more accessible.

，让整体的、数据驱动的健康解决方案更加触手可及。

'The human microbiome is pivotal to health, and this acquisition positions us as a leader in this area. We gain exceptional expertise in metagenomics, transcriptomics, and targeted metabolomics to serve academic, biotech, and clinical sectors,' declared Anu Acharya, Founder and CEO of Mapmygenome. 'This accelerates our North American footprint aligning with our strategic vision of growth through targeted acquisitions leading up to our listing on the Indian market later this year'.

“人类微生物组对健康至关重要，此次收购使我们成为这一领域的领导者。我们获得了在宏基因组学、转录组学和靶向代谢组学方面的卓越专业知识，以服务学术、生物技术和临床领域，”Mapmygenome创始人兼首席执行官Anu Acharya表示。“这加速了我们在北美的布局，符合我们通过有针对性的收购实现增长的战略愿景，并为我们今年晚些时候在印度市场上市做好准备。”

'Joining forces with Mapmygenome, provides the resources and capabilities to offer higher quality services to our clients and accelerate growth. The combination of their expertise in AI-driven genomics solutions and our deep microbiome expertise will result in a new standard of cutting-edge services for clients worldwide,' said .

“与Mapmygenome联手，提供了资源和能力，以为我们的客户提供更高质量的服务并加速增长。他们在人工智能驱动的基因组学解决方案方面的专业知识与我们在微生物组方面的深厚专业知识相结合，将为全球客户带来新的尖端服务标准，”该公司表示。

Malcolm Kendall

马尔科姆·肯德尔

, CEO of Microbiome Insights.

，Microbiome Insights首席执行官。

Financial terms were not disclosed.

财务条款未披露。

About Mapmygenome:

关于Mapmygenome：

Founded a decade ago, we are a leading genomics company driven by pioneering research and a vision for preventive healthcare. We harness AI-driven genomic and microbiome testing to deliver personalized health solutions, with offerings like at-home DNA tests for proactive health and longevity. For healthcare providers, our diagnostic genomic tests are conducted in a CAP-accredited lab, ensuring high accuracy, complemented by genetic counseling..

十年前成立，我们是一家领先的基因组学公司，以开创性研究和预防医疗保健的愿景为驱动力。我们利用人工智能驱动的基因组和微生物组检测，提供个性化健康解决方案，包括用于主动健康和长寿的居家DNA检测。对于医疗保健提供者，我们的诊断基因组检测在CAP认证的实验室中进行，确保高准确性，并辅以遗传咨询。

About Microbiome Insights:

关于微生物组洞察：

We are a global leader providing end-to-end microbiome sequencing and comprehensive bioinformatic analysis. Collaborating with pharma, biotech, nutrition, cosmetic, and agriculture clients, alongside leading academic and government institutions, we've supported over 1,000 studies, from basic research to clinical trials, and biomarker discovery to machine-learning based modeling..

我们是提供端到端微生物组测序和全面生物信息学分析的全球领导者。我们与制药、生物技术、营养、化妆品和农业客户以及领先的学术和政府机构合作，已经支持了1000多项研究，从基础研究到临床试验，再到生物标志物发现及基于机器学习的建模。

Photo:

照片：

https://mma.prnewswire.com/media/2698768/Mapmygenome.jpg

Logo:

标志：

https://mma.prnewswire.com/media/2698769/Mapmygenome_Logo.jpg

SOURCE Mapmygenome

来源 Mapmygenome

WANT YOUR COMPANY'S NEWS

想要你公司的新闻吗

FEATURED ON PRNEWSWIRE.COM?